Win for Kenya as Ministry Launches Long-Acting HIV Prevention Injection

Kenya has officially launched Lenacapavir, a long-acting injection for HIV prevention, marking a significant step in efforts to reduce new infections and strengthen the national HIV response.

The launch presided over by Health Cabinet Secretary Hon. Aden Duale on February 26, 2026, took place at Riruta Health Centre in Nairobi.

The Ministry of Health described the rollout as a major boost to the country’s prevention strategy.

Speaking during the event, CS Duale termed the introduction of Lenacapavir “a milestone in our prevention efforts,” noting that about 1.4 million Kenyans are currently living with HIV, with thousands of new infections recorded annually.

He emphasised the need to expand innovative prevention options to reverse transmission trends and better protect vulnerable populations.

Regulatory Approval and Safety Assurance

The Cabinet Secretary confirmed that the medicine has met all regulatory and procurement requirements under Kenyan law and health guidelines.

“Lenacapavir underwent rigorous international scientific review and local evaluation by the Pharmacy and Poisons Board, with support from the Global Fund,” he said.

Also Read: DPP Directs Charges Against Hospitals and Individuals Accused of Stealing from SHA [FULL LIST]

Health officials confirmed that safety, quality and effectiveness standards were fully assessed before approval and rollout.

Twice-Yearly Injection, Free for Eligible Kenyans

The injection will be administered twice a year and offered free of charge to eligible individuals at selected public health facilities in priority counties.

According to the Ministry, the rollout will follow a phased and structured approach, guided by trained healthcare professionals to ensure safe, equitable and responsible access.

Kenya Among First Countries to Roll Out Lenacapavir

Kenya is among the first countries globally to introduce Lenacapavir for HIV prevention -a move that signals international confidence in the country’s health systems and its ability to deliver cutting-edge medical innovations.

Also Read: KMTC Announces Fully Funded Scholarships for Select Students – How to Apply

The event was attended by Principal Secretary for Medical Services Dr. Ouma Oluga, NASCOP CEO Dr. Andrew Mulwa, Family Health Director Dr. Issak Bashir, Dagoretti North MP Hon. Beatrice Elachi and development partners, including representatives from the Global Fund, UNAIDS, WHO, the US Government and AHF.

In a tweet, the Ministry of Health hailed the development as a breakthrough in the fight against HIV, describing the launch as a significant win for Kenya’s public health sector.

Follow our WhatsApp channel for instant news updates